Experts call for better design of early drug trials for Alzheimer's and related dementias

(Alzheimer's Drug Discovery Foundation) An expert panel convened by the Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration provides guidance on best practices for the design of early drug trials for neurodegenerative dementias. Their guidance was published in the May 18, 2021 issue of Neurology®.